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We investigate chemo-photothermal effects of gold nanorods (GNRs) coated using mesoporous
silica (mSiO2) loading doxorubicin (DOX). When the mesoporous silica layer is embedded by dox-
orubicin drugs, a significant change in absorption spectra enable to quantify the drug loading.
We carry out photothermal experiments on saline and livers of mice having GNRs@mSiO2 and
GNRs@mSiO2-DOX. We also inject the gold nanostructures into many tumor-implanted mice and
use laser illumination on some of them. By measuring weight and size of tumors, the distinct effi-
ciency of photothermal therapy and chemotherapy on treatment is determined. We experimentally
confirm the accumulation of gold nanostructures in liver.
I. INTRODUCTION
Photothermal effects of gold nanorods have been ex-
tensively investigated due to medical applications [1–6].
When shined by light, gold nanorods (GNR) absorb ra-
diation and confine electromagnetic energy to the sur-
face of a golddielectric interface. The absorbed energy
is efficiently transformed into thermal energy and locally
heats to a few hundred degree Celsiuses under illumina-
tion of laser light. Since destruction of living cells occrus
at temperatures above 43 0C, this light-to-heat conver-
sion process is used for cancer therapy [1–6]. In synthesis
of gold nanostructures using cetyl trimethylammonium
bromide (CTAB), their gold surfaces become unstable
and easily aggregate. This aggregation causes the loss of
unique optical properties. Moreover, it has been proved
that CTAB is a highly toxic cationic surfactant [7, 8].
To exploit GNRs for biomedical applications, it is nec-
essary to replace CTAB and coat GNRs by safer and
more biocompatible materials/molecules. Recently, ex-
tensive efforts have been devoted to encapsulate GNRs
with mesoporous silica [9, 10], bio-polymers [11, 12], or
other composites [13, 14]. These coating materials can be
easily combined with drugs or target molecules to func-
tionalize GNRs.
In some biological and photothermal applications,
GNRs is preferred rather than gold nanoshells (GNSs)
because of two main reasons. First, the size of GNSs
having plasmon resonances in the near-infrared region is
large (∼ 150nm) [15, 16], while the size of GNRs is small
(≤ 80 nm) [1–6]. According to previous works [17, 18],
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sub-100 nm nanoparticles are selected for treatments due
to their free movement through tissues. Second, it is well
known that GNRs have a strong optical absorption cross
section and a very small scattering cross section [19, 20].
These behaviors are relatively opposite to properties of
large size GNSs. Thus, the GNRs are more photother-
mally efficient than the GNSs [19, 20].
While doxorubicin is an anthracycline antibiotic known
as one of the most therapeutic anti-tumor drugs to treat
various solid malignant tumors. Doxorubicin interca-
lates within DNA helix in the cell nucleus. Thereby,
this drug inhibits macromolecular biosynthesis and de-
stroys DNA function [21]. However, free DOX has its
own several side effects when used in cancer chemother-
apy [22]. To reduce the toxicity and side effects and im-
prove treatment efficiency, one encapsulates DOX in li-
posomes [23], loads onto silica mesoporous nanoparticles
[24], or incorporates into nanocomposites such as silica
mesoporous encapsulated GNRs [25], GNR@mSiO2 or
GNR@polymers [9, 12]. Doxorubicin release and load-
ing from GNR@mSiO2-DOX or GNR@polymer-DOX
strongly depend on acidic medium and laser irradiation
at surface plasmon resonances [9]. The synergistic effect
of the drug loaded GNR@SiO2 has been demonstrated
[9, 14, 22].
There have recently been clinical trials for gold-
nanoparticle-based photothermal cancer therapy to ab-
late thermally neck, brain, lung, and prostate cancerous
tumors [9, 26–28]. These results showed promising sce-
narios since tumors were locally heated. However, ac-
cumulation of gold nanostructures in liver and spleen
throughout life in bodies without excrete is the most
weakest point of this approach [27, 28]. The penetra-
tion of gold composites into tumors is tiny compared to
the infused initial counterparts.
In this work, we synthesize GNRs@mSiO2-DOX and
investigate photothermal and chemical behaviors of
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2nanostructures under laser irradiation. We use transmis-
sion electron microscopy (TEM) and X-ray diffraction
(XRD) spectrum to analyze structures of experimental
samples. Effects of DOX loading on optical properties
are determined using the absorption spectrum. Then,
we inject solutions of GNRs@mSiO2 with and without
DOX molecules into 45 normal and tumor-planted mice
and study chemo-photothermal activities. Based on ex-
perimental results, we quantitatively evaluate roles of in-
dividual mechanism on cancer treatments.
II. EXPERIMENTAL SECTION
A. Materials
We purchased tetrachloroauric acid trihydrate 99.5 %
(HAuCl4 · 3 H2O), ethanol, CTAB, ascorbic acid, and
AgNO3 from Merck. Tetraethoxylsilane and NH4OH (28-
30 %), and NaBH4 were purchased from Sigma-Aldrich
and Walko, respectively. Doxorubicin hydrochloride 2
mg/ml was provided by Ebewe Pharma. In our experi-
ments, we dispersed materials into double distilled water.
B. Preparation and characterization of
GNR@SiO2-DOX complex
The synthesis of GNR@SiO2-DOX composites con-
sists of three steps. First, we synthesized near-infrared
light-responsive GNRs. Second, a mesoporous silica
layer is coated on gold surfaces. A thickness of the
silica layer is approximately 15 nm. Third, when
dispersing DOX.HCl molecules in an aqueous solution
of GNSs, the mesoporous silica surface adsorbed the
biomolecules onto the mesoporous silica surface via elec-
trostatic interactions. Finally, we obtained mesoporous
silica-encapsulated GNRs (GNR@mSiO2-DOX) compos-
ites loading DOX molecules.
1. Preparation of GNRs
Gold nanorods having dimensions of ∼ 39.2× 10.7 nm
(an average aspect ratio of 3.7) were synthesized using
the seed-mediated growth method [29]. Briefly, the seed
was made by stirring 120 µl of 25 mM HAuCl4 in 10
ml of 100 mM CTAB solution. Then, we quickly added
ice-cold NaBH4(60 µl, 10 mM) to the seed solution and
stirred for 2-6 hours. By mixing 100 ml of CTAB 100
mM, 1.5 ml of HAuCl4 25 mM, 450 µl of AgNO3 25 mM
and 270 µl of L-ascorbic acid 100 mM, a growth solution
was prepared. After 2 hours of reaction in a mixture of
1000 µl of the seed solution and the growth solution, the
GNR seeds were synthesized.
2. Preparation of mesoporous silica-encapsulated GNRs
GNRs were prepared by a seed-mediated sequential
growth and a reduction of gold salt in the presence of
in the presence of a CTAB surfactant. A 20 ml aliquot of
the GNRs solution was centrifuged and re-dispersed in 20
ml deionized water. Then, we added 0.5 ml of the TEOS
ethanol solution (20 mM) to 20 mL of GNR aqueous so-
lution (pH is adjusted to 10-11 by mixing NH4OH). Af-
ter vigorously stirring for 24 hours at room temperature,
there was a 15nm thick mesoporous silica layer forming
on the surface of the GNRs through hydrolysis and con-
densation of TEOS. The silica-encapsulated GNRs were
isolated by centrifugation, washed with deionized water
and ethanol several times, and then re-dispersed in 2 ml
of deionized water for later use.
3. Mesoporous silica-encapsulated GNRs functionalized
with doxorubicin drugs
We added 200 µl of DOX.HCl 2-mg/mL solution to a
solution of GNRs@mSiO2 solution which has the optical
density (OD) equal to 12. Then, this mixture was stirred
and mixed during 75h at room temperature in the dark.
Electrostatic interaction between doxorubicin molecules
and the mesoporous silica surface leads to molecular ad-
sorption at particle surfaces [30, 31]. Finally, we used
UV-VIS-NIR spectrometer to monitor the adsorbing pro-
cedure of DOX into mesoporous silica surface.
4. Measurements
In the final GNR suspension, GNRs@mSiO2 and
GNRs@SiO2DOX were characterized by an ultravio-
let/visible wavelength (UV-VIS-NIR) spectrophotometer
(Shimadzu 2600) and dynamic light scattering. We ex-
amined sizes and shapes of GNRs by high resolution
transmission electron microscopy (HRTEM, JEM2100-
JEOL). Samples were prepared by placing one drop of the
GNR suspension on a 200-mesh, copper grid with carbon
(SPI Supplies, West Chester, Pennsylvania), and drying
in a vacuum oven overnight. We used X-Ray diffraction
to determine the chemical composition and crystalline of
the obtained GNRs.
C. In-vivo experiments
For in vivo experiments, we used healthy male Swiss
Albino mice (810 weeks old) with weight of 18± 1.5 g.
The mice had free access to food and water and were
maintained on a 14/10 h light/dark cycle. The sar-
coma cancer cells were subcutaneously implanted (2×106
cells/100 µl of Hanks solution) into the right side of
mouse back. The tumor size was daily measured. These
animals were examined when their average tumor size
3grew up to 5-6 mm diameter. We randomly divided forty
five mice into nine groups (five mice per groups): one con-
trol group and eight experimental groups with two differ-
ent concentrations of GNR@mSiO2 and GNR@mSiO2-
DOX having optical density of 5.5 and 9.2 at 808 nm
under 808-nm laser irradiation. Particularly, the groups
are
- Control group: without tumor and no treatment.
- Group 1: saline injection.
- Group 2: saline injection + 808-nm laser irradiation;
- Group 3: GNR@mSiO2 OD = 9.2.
- Group 4: GNR@mSiO2-DOX OD = 9.2
- Group 5: GNR@mSiO2 OD = 5.5 + 808-nm laser
irradiation.
- Group 6: GNR@mSiO2 OD = 9.2 + 808-nm laser
irradiation.
- Group 7: GNR@mSiO2-DOX OD = 5.5 + 808-nm
laser irradiation.
- Group 8: GNR@mSiO2-DOX OD = 9.2 + 808-nm
laser irradiation.
We used a 1 ml syrring 26G needle to inject di-
rectly 30 µl of phosphate-buffered saline (PBS) 1x or
GNR@mSiO2/GNR@SiO2-DOX solutions into each tu-
mor center of mice. The animals were irradiated with
laser (808 nm, 3.25 W/cm2, 1 minute, a spot size of 6
mm) immediately after tumor-direct injection. The laser
was focused on the center of the tumor. We measured the
temperature rise of tumor surface by an infrared (IR)
camera (Chauvin Arnoux C.A 1995 IR camera IP 54).
After treatment, we observed health and weight of mice.
After 1 month, all mice were euthanized. We dissected
their tumors and measured their weight. Average body
weights of nine groups of mice as a function of time were
shown in Figure S1 in Supporting Information. At that
time, we also analyzed blood chemistry and hematology.
All experiments were performed in compliance with the
policy on animal use and ethics.
III. RESULTS AND DISCUSSIONS
Figure 1a and 1b show TEM images of a solution of
GNRs and GNR@mSiO2, respectively. The TEM images
indicate that the average length and width are 39.2± 6.2
nm and 10.7±1.7 nm, respectively, (the average aspect
ratio of 3.7). The silica shell is uniform and has thick-
ness of ∼ 15 nm. One can see a TEM image of the meso-
porous silica coating on GNRs in Figure S2 in Supporting
Information.
Figure 1c shows X-ray diffraction of GNRs to deter-
mine their chemical composition and crystalline. We find
three characteristic diffraction peaks at 38.270, 44.420,
and 64.700 corresponding to the (111), (200), and (220)
crystal planes of the face-centered cubic structure of gold
(JCPDS no. 04-0784), respectively. The presence of
these optical maxima indicates a polycrystalline struc-
ture of GNRs. In addition, since there is no other impuri-
ties in the diffraction patterns, our samples are composed
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FIG. 1: (Color online) TEM image of (a) GNRs and (b)
GNRs@mSiO2 with scale bar of 100 nm, and (c) X-ray diffrac-
tion spectrum of GNRs.
of pure crystalline gold.
Figure 2 shows normalized absorption spectra of GNRs
(or CTAB-GNRs) and GNR@mSiO2. Note that GNRs
have CTAB molecules on the surface to stabilize and
avoid aggregation. In each spectrum, two peaks corre-
sponds to the transverse (∼513 nm) and longitudinal
(∼820 nm) oscillation. The surface plasmon resonance
of GNRs is strongly dependent on their aspect ratio [20].
An increase of the aspect ratio leads to a red-shift of
the optical peak. However, our results indicates the sil-
ica layer has a minor effect on the absorption spectrum.
This may be due to a broad distribution of the rod length
and width of GNRs as shown in Figure S3 in Supporting
Information. This behavior is completely consistent with
experimental results in Ref. [32].
Compared to the optical spectrum of CTAB-GNRs,
the longitudinal surface plasmon resonance band of
GNR@mSiO2 is slightly red-shifted about 6 nm. Mean-
while, the peak location for the transverse plasmon band
of CTAB-GNRs is at 513 nm and this resonance is blue-
shifted about 4 nm when coating silica on the gold sur-
face. This behavior can be explained that the refractive
index of silica shell (1.45) is closer to that of water media
(1.33) than that of 2-3 nm CTAB layer (1.49). It means
the silica layer provides more transmission and lower re-
flection of electromagnetic fields than the CTAB layer.
Thus, more electrons of the GNR core are excited to col-
lectively resonate. The shift of optical resonances as in-
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FIG. 2: (Color online) Normalized absorption spectra of
GNRs and GNR@mSiO2.
creasing the refractive index of the medium surrounding
the core is predictable.
The DOX loading of GNRs@mSiO2 can be analyzed
using the absorption spectra. As shown in Figure 3,
the absorption spectra of GNR@mSiO2 is blue-shifted af-
ter adsorbing DOX. Doxorubicin molecules in the meso-
porous silica layer enhance the absorbance intensity of
the transverse peak near 500 nm but do not affect the
absorbance of the longitudinal peak located at about 813
nm. This is because DOX molecules strongly absorb
light at 500 nm and do not interact with NIR radia-
tion. After 75 hours incubation, the optical spectrum
of GNR@mSiO2-DOX is lowered in comparison with the
spectrum measured immediately before and after mixing
DOX. These results indicate that DOX molecules tightly
bind to the silica layer of GNR@mSiO2 but biological
degradation may appear [33].
Free and absorbed DOX molecules can be separated
using centrifugation. We removed the supernatant with
a pipet and determined the concentration of the residual
DOX in the supernatant by measuring its absorbance
and then comparing this measured spectrum with that of
known concentrations of free DOX solution. From this,
we estimated that 1 µg of Au approximately absorbs 1.3
µg of DOX.
Under NIR 808-nm laser irradiation with power den-
sity at 3.25 W/cm2 for 1 minute, GNRs@mSiO2 and
GNRs@mSiO2-DOX in solutions absorb the light en-
ergy and convert it into heat. Solutions of plasmonic
nanocomposites are fixed at the same optical density
of 3.6 at 808 nm. During the laser illumination, as
shown in Figure 4, temperature of GNR@mSiO2 and
GNR@mSiO2DOX solutions rapidly increases from room
temperature to approximately 70.5 0C. Theoretically,
by using the energy balance equation in homogeneous
and open systems, one derives an analytical fitting func-
tion T (t) = T0 +
A
B
(
1− e−Bt) to describe the time-
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FIG. 3: (Color online) Absorption spectra of free DOX at
concentration 30 µg/ml, GNR@mSiO2, GNR@mSiO2−DOX
(30 µg/ml) at 0 hour and after 75 hours of incubation.
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FIG. 4: (Color online) Time-dependent temperature of
GNR@mSiO2, GNR@mSiO2-DOX solutions with optical den-
sity of 3.6 and saline irradiated with the NIR laser (808
nm, 3.25W/cm2). The solid curve is an analytic function
T (t) = T0 +
A
B
(
1− e−Bt) with T0 = 24.67 0C, A ≈ 3.168
0Cs, and B = 0.0773 s−1.
dependent temperature [15, 34]. The analysis agrees
quantitatively well with our experimental data. The
temperature rises of these solutions relatively overlap.
This result can be deduced from Figure 3 since the pres-
ence of DOX molecules does not alter the absorbance
of GNR@mSiO2 in the NIR region. Thus, aqueous so-
lutions of GNR@mSiO2 and GNR@mSiO2DOX absorb
energy and are heated in the same manner. While the
temperature is nearly unchanged in saline solution.
Furthermore, since the absorption spectrum of GNRs
with and without a mesoporous silica layer on the gold
5surface have a very small variation (see Figure 2), one
could expect a perfect overlapping between the time-
dependent temperature rise of GNR solution and that
of GNR@mSiO2 solution.
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FIG. 5: (Color online) The liver of control mouse image with-
out GNR infusion image before (a) and after (b) irradiated by
NIR laser irradiation (808 nm, 3.5 W/cm2, 2 minutes). The
liver of mouse image with 150 µl, OD = 10 of GNR@mSiO2
infusion before (c) and after (c) NIR laser radiation (808 nm,
3.25 W/cm2, 2 minutes). (e) Temperature rises of mice liver
at the three different positions after vein tail injection 2 hours
in (b) and (d). The dashed-dotted violet curve is the ana-
lytic function T (t) = T0 +
A
B
(
1− e−Bt) with T0 = 27.29 0C,
A ≈ 1.36 0Cs, and B = 0.025 s−1.
Examing chemo-photothermal effects of nanocompos-
ites on animals is an essential part to step towards prac-
tical applications. In addition to investigations of the
time-dependent temperature rise, the liver accumula-
tion of nanostructures has been intensively concerned in
medical-related fields. Several recent works used the dose
for intravenous administration of GNRs ranging from 1.7
mg · kg–1 to 25 mg · kg–1 [9, 35]. It was proved that the
amount of GNRs is accumulated in internal organs, par-
ticularly in liver and spleen after infusion. In the remain-
ing life, GNRs cannot be excreted from their bodies [27].
Another study showed that gold nanoparticles are mainly
trapped in the Kuffer macrophage cells in the liver for 2
hours after intravenous injection [36].
In our work, to test the accumulation of GNR@mSiO2
in the liver, we used low doses (100 µl of saline buffer and
GNR@mSiO2 1.75 mg · kg–1) to inject into mice. For
two hours after intravenous injection, mice were sacri-
ficed and their livers were taken. The presence and in-
fluences of GNRs in the livers were determined via pho-
tothermal effects. Under the same conditions of in vivo
experiments, we illuminated livers at the three different
positions (P1, P2, and P3 as depicted in Figure 5b and
5d) within 2 min of NIR laser (808 nm, 3.25 W/cm2).
For livers without GNRs, Figure 5a and 5b show no
difference (visual) between before and after laser radi-
ation at three irradiated positions. Meanwhile, for liv-
ers of mice with tail vein injection of GNR@mSiO2 solu-
tions, one visually observes color change of the liver after
laser radiation in Figure 5d. Color at these three posi-
tions irradiated by laser turns yellow compared to Figure
5c. This indicates the presence of gold nanostructures in
the liver and the accumulation leads to the heat-induced
denaturation of organs. The time-dependent tempera-
ture rises of livers at positions P1, P2, and P3 in Figure
5b and d, which correspond samples injected by saline
buffer and GNR@mSiO2, respectively, were monitored
and shown in Figure 5e. The temperatures of experi-
mental samples with GNRs@mSiO2 increase up to 85±2
0C after 2 minutes. For liver with only saline, the tem-
perature slowly increases and reaches to 44±1 0C. There
is no much difference between temperatures at the irra-
diated points. This finding suggests that the liver is an
approximately homogeneous medium and GNRs@mSiO2
are randomly distributed. Again, the mathematical form
of the time-dependent temperature obeys the fit equation
T (t) = T0 +
A
B
(
1− e−Bt).
The chemo- and photothermal therapies in mice due
to the use of GNR@SiO2 and GNR@SiO2-DOX are also
investigated by the implanted mouse tumor models as
described in Section II. C. Figure 6a shows photographs
of tumors taken from 8 animal groups after 30 days
treatment. We measured the average tumor weight of
each group. The results are shown in Figure 6b to
quantify contribution of chemotherapy and photother-
mal therapy. Overall, the presence of GNR@SiO2 and
GNR@SiO2-DOX without laser exposure destroys tumor
cells. Treatment efficiency of using laser illumination
on tumors without plasmonic nanostructures is better
than just only using GNRs@SiO2 without laser illumi-
nation. However, coating DOX molecules onto the plas-
monic composites (group 4) approximately reduces the
tumor volume and weight by a factor of 1.5 and 2.7 com-
pared to only GNR@SiO2 (group 3) and saline injection
(group 1), respectively. By turning on the NIR laser light
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FIG. 6: (Color online) (a) Photograph of tumors after exci-
sion from 8 groups. (1) untreated group, (2) laser only, (3)
treatment with GNR@SiO2 OD = 9.2, (4) treatment with
GNR@SiO2-DOX OD = 9.2. (5) and (6) treatment with
GNR@SiO2 OD = 5.5 and 9.2, respectively, (7) and (8) treat-
ment with GNR@SiO2-DOX OD = 5.5 and 9.2, respectively,
and under NIR laser irradiation (808 nm, 3.25 W/cm2, 1
minute). (b) The average tumor weights of each group.
when tumors have GNR@SiO2-DOX, we combine effects
of the anti-cancer drug and photothermal agents. This
combination significantly enhances the efficiency and ef-
fectiveness of GNR@SiO2-DOX dose. Using more pho-
tothermal agents enables to absorb more optical energy
to thermally devastate tumor tissue. One can deduce this
conclusion from comparing group 7 and 8, which corre-
spond injections with the optical density of 5.5 and 9.2,
respectively.
IV. CONCLUSIONS
We have validated anti-cancer effects of the chemo-
photothermal therapy based on GNR@SiO2-DOX by in
vivo experiments. We have experimentally prepared
GNR@SiO2-DOX and examined complex structures via
SEM and TEM imagine, and XRD technique. Based on
absorption spectra, one can observe variations of plas-
monic properties of GNRs of size 10.7 nm × 39.2 nm
when coating a mesoporous silica layer on the gold sur-
face and encapsulating DOX molecules onto this silica
layer. Moreover, these optical spectra allow us to de-
termine the amount of loaded DOX molecules. After
injecting solutions of the GNR@SiO2 and GNR@SiO2-
DOX into mice and scarifying them, photothermal ex-
periments are carried out in both water and livers of
mice. These experiments proves that GNRs@SiO2 are ac-
cumulated in livers. The mice liver can be approximately
considered as a homogeneous medium and the injected
GNRs are randomly dispersed in the liver when injected
into mice. When we inject solutions of GNRs@SiO2 and
GNRs@SiO2-DOX into tumor-implanted mice and irra-
diate NIR laser light on their tumors within 1 minute im-
mediately after direct injection, health and weight of mice
are observed everyday for one month. Then, their tumors
are taken to measure weight. All measurements explic-
itly indicate that both chemotherapy and photothermal
therapy significantly reduce tumor volumes. More re-
duction of volumes is found when combining these two
approaches.
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